Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer LimitedfiledCriticalPfizer Limited
Priority to CU20080042ApriorityCriticalpatent/CU23564A3/en
Publication of CU23564A3publicationCriticalpatent/CU23564A3/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invención se refiere a compuestos de fórmula ESPACIO PARA FÓRMULA (I) a procedimientos e intermedios para su preparación, asu uso como antagonistas muscarínicos y a la composición farmacéutica que los contiene.The invention relates to compounds of the formula SPACE FOR FORMULA (I) to procedures and intermediates for their preparation, their use as muscarinic antagonists and the pharmaceutical composition containing them.
CU20080042A2008-03-202008-03-20
CARBOXAMIDE DERIVATIVES AS ANTAGONISTS OF THE MUSCARINIC RECEIVER
CU23564A3
(en)
NEW DERIVATIVES OF 6-TRIALZOLOPIRIDACINA-SULFANIL BENZOTIAZOL AND BENCIMIDAZOL, ITS PREPARATION PROCEDURE, ITS APPLICATION AS MEDICATIONS, PHARMACEUTICAL COMPOSITIONS AND NEW MAIN USE AS MET INHIBITORS.
Compounds derived from spiropiperidine-methylbenzyloxyphenyl, activators of the rpg-40 receptor; pharmaceutical composition comprising them; and use of the compound to treat diabetes.